Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Philadelphia Chromosome Negative, BCR-ABL1 Positive Chronic Myelogenous Leukemia”

78 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 78 results

Early research (Phase 1)Study completedNCT00807677
What this trial is testing

Dose Escalation Study of TAK-901 in Subjects With Advanced Hematologic Malignancies

Who this might be right for
Acute Myeloid LeukemiaAcute Lymphoblastic LeukemiaChronic Myelogenous Leukemia+9 more
Millennium Pharmaceuticals, Inc. 31
Large-scale testing (Phase 3)UnknownNCT00002869
What this trial is testing

Interferon Alfa in Treating Patients With Newly Diagnosed Chronic Myelogenous Leukemia

Who this might be right for
Leukemia
Medical Research Council 800
Testing effectiveness (Phase 2)Study completedNCT01274351
What this trial is testing

Study of Nilotinib as First Line Treatment in Philadelphia Chromosome Positive(Ph+) Chronic Myelogenous Leukemia in Chronic Phase (CML-CP)

Who this might be right for
Chronic Myelogenous Leukemia
Novartis Pharmaceuticals 112
Testing effectiveness (Phase 2)Study completedNCT00006052
What this trial is testing

STI571 in Treating Patients With Accelerated Phase Chronic Myelogenous Leukemia

Who this might be right for
Leukemia
Novartis
Testing effectiveness (Phase 2)Study completedNCT01844765
What this trial is testing

Open Label, Phase II Study to Evaluate Efficacy and Safety of Oral Nilotinib in Philadelphia Positive (Ph+) Chronic Myelogenous Leukemia (CML) Pediatric Patients.

Who this might be right for
Philadelphia Positive (Ph+) Chronic Myelogenous Leukemia
Novartis Pharmaceuticals 59
Large-scale testing (Phase 3)Study completedNCT02326311
What this trial is testing

Optimization of TKIs Treatment and Quality of Life in Ph+ CML Patients ≥60 Years in Deep Molecular Response

Who this might be right for
Leukemia, Chronic Myeloid
Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia 229
Post-approval studies (Phase 4)Ended earlyNCT01131325
What this trial is testing

Study of Nilotinib in Ph+ CML-CP Patients With Low Imatinib Trough Plasma Concentrations

Who this might be right for
CMLPhiladelphia Chromosome Positive (Ph+)Chronic Myelogenous Leukemia Chronic Phase(CML-CP) Patients With Low Imatinib Trough Levels
Novartis Pharmaceuticals 3
Testing effectiveness (Phase 2)Active Not RecruitingNCT01424982
What this trial is testing

Combination Chemotherapy and Ponatinib Hydrochloride in Treating Patients With Acute Lymphoblastic Leukemia

Who this might be right for
Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 PositiveAcute Lymphoblastic LeukemiaAdult Acute Lymphoblastic Leukemia in Complete Remission+4 more
M.D. Anderson Cancer Center 88
Large-scale testing (Phase 3)UnknownNCT00025402
What this trial is testing

Chemotherapy and Biological Therapy With or Without Bone Marrow or Peripheral Stem Cell Transplant in Treating Patients With Chronic Myelogenous Leukemia

Who this might be right for
Leukemia
III. Medizinische Klinik Mannheim 1,000
Early research (Phase 1)Study completedNCT00316953
What this trial is testing

Dasatinib in Treating Young Patients With Recurrent or Refractory Solid Tumors or Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia or Chronic Myelogenous Leukemia That Did Not Respond to Imatinib Mesylate

Who this might be right for
Accelerated Phase Chronic Myelogenous LeukemiaBlastic Phase Chronic Myelogenous LeukemiaChildhood Chronic Myelogenous Leukemia+5 more
National Cancer Institute (NCI) 48
Testing effectiveness (Phase 2)Study completedNCT01698905
What this trial is testing

Treatment-free Remission After Achieving Sustained MR4.5 on Nilotinib (ENESTop)

Who this might be right for
Chronic Myeloid Leukemia
Novartis Pharmaceuticals 163
Post-approval studies (Phase 4)Active Not RecruitingNCT06427811
What this trial is testing

Clinical Study of Asciminib in Previously Treated Indian Patients With Ph+ CML-CP Without T315I Mutation and in Patients With Ph+ CML-CP With T315I Mutation

Who this might be right for
Philadelphia Chromosome-Positive Chronic Myeloid Leukemia in Chronic Phase
Novartis Pharmaceuticals 85
Testing effectiveness (Phase 2)Study completedNCT00769327
What this trial is testing

Nilotinib and Imatinib Mesylate in Treating Patients With Early Chronic Phase Chronic Myelogenous Leukemia

Who this might be right for
Leukemia
Gruppo Italiano Malattie EMatologiche dell'Adulto 129
Testing effectiveness (Phase 2)Study completedNCT03578367
What this trial is testing

Study of Efficacy and Safety of Asciminib in Combination With Imatinib in Patients With Chronic Myeloid Leukemia in Chronic Phase (CML-CP)

Who this might be right for
CMLChronic Myelogenous LeukemiaLeukemia, Myeloid Chronic+1 more
Novartis Pharmaceuticals 104
Large-scale testing (Phase 3)Active Not RecruitingNCT04971226
What this trial is testing

Oral Asciminib Versus Other TKIs in Adult Patients With Newly Diagnosed Ph+ CML-CP

Who this might be right for
Chronic Myeloid Leukemia (CML) Philadelphia Chromosome Positive
Novartis Pharmaceuticals 406
Large-scale testing (Phase 3)Temporarily pausedNCT01755325
What this trial is testing

Phase III Study of Compound Formula Realgar-Indigo Naturalis Plus Imatinib Versus Placebo Plus Imatinib in Adult CML-CP Patients With Ph+

Who this might be right for
Chronic Myelogenous Leukemia
Junmin Li 680
Testing effectiveness (Phase 2)Looking for participantsNCT03263572
What this trial is testing

Blinatumomab, Methotrexate, Cytarabine, and Ponatinib in Treating Patients With Philadelphia Chromosome-Positive, or BCR-ABL Positive, or Relapsed/Refractory, Acute Lymphoblastic Leukemia

Who this might be right for
Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 PositiveAcute Lymphoblastic LeukemiaBCR-ABL1 Fusion Protein Expression+5 more
M.D. Anderson Cancer Center 90
Testing effectiveness (Phase 2)Study completedNCT00030394
What this trial is testing

Imatinib Mesylate in Treating Patients With Chronic Myelogenous Leukemia

Who this might be right for
Childhood Chronic Myelogenous LeukemiaChronic Myelogenous Leukemia, BCR-ABL1 PositiveChronic Phase Chronic Myelogenous Leukemia
National Cancer Institute (NCI) 64
Testing effectiveness (Phase 2)Study completedNCT00381550
What this trial is testing

3-AP and Fludarabine in Treating Patients With Myeloproliferative Disorders, Chronic Myelomonocytic Leukemia, or Accelerated Phase or Blastic Phase Chronic Myelogenous Leukemia

Who this might be right for
Accelerated Phase Chronic Myelogenous LeukemiaAtypical Chronic Myeloid Leukemia, BCR-ABL1 NegativeBlastic Phase Chronic Myelogenous Leukemia+7 more
National Cancer Institute (NCI) 35
Testing effectiveness (Phase 2)Study completedNCT01784068
What this trial is testing

Nilotinib Treatment-free Remission Study in CML (Chronic Myeloid Leukemia) Patients

Who this might be right for
Chronic Myelogenous Leukemia
Novartis Pharmaceuticals 215
Load More Results